Investing Profile

Kenan Turnacioglu

Angel
General Partner & Member of the Investment Committee at Catalio Capital Management
New York City
Photo of Kenan Turnacioglu, General Partner at Catalio Capital Management

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Pennsylvania Network
438 CONNECTIONS
Credit Suisse Network
280 CONNECTIONS
Mount Auburn Hospital Network
102 CONNECTIONS
Rutgers University Network
64 CONNECTIONS
The Johns Hopkins University School of Medicine Network
15 CONNECTIONS
cb
$5K - $50K
$25K
5
CompanyStageDateRound SizeTotal Raised
Network Bio
SeedFeb 2025$17M
$20M
Co-investors: Stuart Peterson (Artis Ventures (AV)), Jason Camm (Thiel Capital), Scott Nolan (The Founders Fund)
Massive Bio
Series AJun 2022$17M
$18M
Co-investors: Gyan Kapur (Surface Ventures)
Immunai
Series AFeb 2021$60M
$60M
Sirona Medical
Series AAug 2020$9M
$91M
Co-investors: Francisco Gimenez (8VC), Andrew Perlman (‎GreatPoint Ventures), Jonathan Bush (Firefly Health)
Paige
Series BDec 2019$45M
$45M
Research associate Credit SuissePresent
Portfolio Manager Duquesne Capital ManagementPresent
Executive Board Member Mount Auburn HospitalPresent
Executive Board Member Stemcentrx, Inc.Present
Board Member ImmunaiPresent
Member Board Of Directors ImmunaiPresent
Board Member Massive BioPresent
Board Member Ratio TherapeuticsPresent
Founding Partner PointState Capital LPPresent
General Partner & Member of the Investment Committee Catalio Capital ManagementPresent
General Partner & Member of the Investment Committee Catalio Capital2020 - 2021
Rutgers University Bachelor of Science - BS Biology and Bachelor of Arts in History
University of Pennsylvania Doctor of Philosophy - PhD Cell/Cellular and Molecular Biology
The Johns Hopkins University School of Medicine Post-Doctoral Genetic mutations in pancreatic cancer
Sign in with Google →
Sign in with Google →